Thyroid autoantibodies and thyroid function in subjects exposed to chernobyl fallout during childhood: Evidence for a transient radiation-induced elevation of serum thyroid antibodies without an increase in thyroid autoimmune disease

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 7, 2008, Pages 2729-2736

  Agate, Laura ^a   Mariotti, Stefano ^b   Elisei, Rossella ^a   Mossa, Paola ^b   Pacini, Furio ^c   Molinaro, Eleonora ^a   Grasso, Lucia ^a   Masserini, Lucio ^a   Mokhort, Tatiana ^d   Vorontsova, Tatiana ^d   Arynchyn, Alexander ^d   Tronko, Mycola D ^e   Tsyb, Anatoly ^f   Feldt Rasmussen, Ulla ^g   Juul, Anders ^h   Pinchera, Aldo ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

^d Research Institute of Radiation Medicine   (Belarus)

^e STATE INSTITUTION NATIONAL RESEARCH CENTER FOR RADIATION MEDICINE OF THE NATIONAL ACADEMY OF MEDICAL SCIENCES OF UKRAINE   (Ukraine)

^f MEDICAL RADIOLOGICAL RESEARCH CENTER   (Russian Federation)

^g Rigshospitalet   (Denmark)

^h UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROID PEROXIDASE; THYROTROPIN;

ADOLESCENCE; ADOLESCENT; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNE THYROIDITIS; CHERNOBYL ACCIDENT; DENMARK; FEMALE; GENDER; HUMAN; ITALY; MALE; PREVALENCE; PRIORITY JOURNAL; RADIATION EXPOSURE; RUSSIAN FEDERATION; SERUM; THYROID DISEASE; THYROID FUNCTION; THYROTROPIN BLOOD LEVEL; UKRAINE;

EID: 47549083513     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-0060     Document Type: Article

References (25)

1. Cardis E, Kesminiene A, Ivanov V, Malakhova I, Shibata Y, Khrouch V, Drozdovitch V, Maceika E, Zvonova I, Vlassov O, Bouville A, Goulko G, Hoshi M, Abrosimov A, Anoshko J, Astakhova L, Chekin S, Demidchik E, Galanti R, Ito M, Korobova E, Lushnikov E, Maksioutov M, Masyakin V, Nerovnia A, Parshin V, Parshkov E, Piliptsevich N, Pinchera A, Polyakov S, Shabeka N, Suonio E, Tenet V, Tsyb A, Yamashita S, Williams D 2005 Risk of thyroid cancer after exposure to 131I in childhood. J Natl Cancer Inst 97:724-732
2. Baverstock K, Egloff B, Pinchera A, Ruchti C, Williams D 1992 Thyroid cancer after Chernobyl. Nature 359:21-22
3. Demidchik E, Kazakov VS, Astakova LN, Okeanov AE, Demidchik YE 1994 Thyroid cancer in children after the Chernobyl accident: clinical and epidemiological evaluation of 251 cases in the Republic of Belarus. In: Nagataki S, ed. Nagasaki symposium on Chernobyl: update and future. Amsterdam: Elsevier; 21
4. Eheman CR, Garbe P, Tuttle M 2003 Autoimmune thyroid disease associated with environmental thyroidal irradiation. Thyroid 13:453-464
5. Pacini F, Vorontsova T, Molinaro E, Kuchinskaya E, Agate L, Shavrova E, Astachova L, Chiovato L, Pinchera A 1998 Prevalence of thyroid autoantibodies in children and adolescents from Belarus exposed to the Chernobyl radioactive fallout. Lancet 352:763-766
6. Vermiglio F, Castagna MG, Volnova E, Lo Priesti VP, Vincenzo P, Moleti M, Violi MA, Artemisia A, Trimarchi F 1999 Post-Chernobyl increased prevalence of humoral thyroid autoimmunity in children and adolescents from a moderately iodine-deficient area in Russia. Thyroid 9:781-786
7. Tronko MD, Brenner AV, Olijnyk VA, Robbins J, Epstein OV, McConnell RJ, Bogdanova TI, Fink DJ, Likhtarev IA, Lubin JH, Markov VV, Bouville AC, Terekhova GM, Zablotska LB, Shpak VM, Brill AB, Tereshchenko VP, Masnyk IJ, Ron E, Hatch M, Howe GR 2006 Autoimmune thyroiditis and exposure to iodine 131 in the Ukrainian cohort study of thyroid cancer and other thyroid diseases after the Chernobyl accident: results from the first screening cycle (1998-2000). J Clin Endocrinol Metab 91:4344-4351
8. Balnov M, Jacob P, Likhtarev I, Minenko V 1996 Pathways, levels, and trends of population exposure after the Chernobyl accident. In: The radiological consequences of the Chernobyl accident. Karaoglou A, Desmet G, Kelly GN, Menzel HG, eds. EUR 16544EN. Brussels-Luxembourg: European Commission; 235-249
9. Tronko M, Kravchenko V, Fink D, Hatch M, Turchin V, McConnell R, Shpak V, Brenner A, Robbins J, Lusanchuk I, Howe G 2005 Iodine excretion in regions of Ukraine affected by the Chernobyl accident: experience of the Ukrainian-American cohort study of thyroid cancer and other thyroid diseases. Thyroid 15:1291-1297
10. Loviselli A, Velluzzi F, Mossa P, Cambosu MA, Secci G, Atzeni F, Taberlet A, Balestrieri A, Martino E, Grasso L, Songini M, Bottazzo GF, Mariotti S, Sardinian Schoolchildren Study Group 2001 The Sardinian autoimmunity study: 3. Studies on circulating antithyroid antibodies in Sardinian schoolchildren: relationship to goiter prevalence and thyroid function. Thyroid 11:849-857
11. Laurberg P 2003 Iodine deficiency disorders in Denmark. J Endocrinol Invest 26(Suppl 9):17
12. Laurberg P, Jorgensen T, Perrild H, Ovesen L, Knudsen N, Pedersen IB, Rasmussen LB, Carlè A, Vejbjerg P 2006 The Danish investigation on iodine intake and thyroid disease, DanThyr: status and perspectives. Eur J Endocrinol [Erratum (2006) 155:643] 155:219-228
13. Demidchik E, Kazakov VS, Astakova LN, Okeanov AE, Demidchik YE 1994 Thyroid cancer in children after the Chernobyl accident: clinical and epidemiological evaluation of 251 cases in the Republic of Belarus. In: Nagataki S, ed. Nagasaki symposium on Chernobyl: update and future. Amsterdam: Elsevier; 21-30
14. Tronko N, Bogdanova T, Kommisarenko I, Bolshova E, Oleynic V, Tereshchenko V, Epshtein Y, Chebotarev V 1996 Thyroid cancer in children and adolescents in Ukraine after the Chernobyl accident (1986-1995). In: Karaoglou A, Desmet G, Kelly GN, Menzel HG, eds. The radiological consequences of the Chernobyl accident. Brussels: European Commission; 683-690
15. Tsyb AF, Parshkov EM, Shaktarin VV, Stepanenko VF, Skvortsov VF, Chebotareva IV 1996 Thyroid cancer in children and adolescents of Bryansk and Kaluga regions. In: Karaoglou A, Desmet G, Kelly GN, Menzel HG, eds. The radiological consequences of the Chernobyl accident. Brussels: European Commission; 691-698
16. Chiovato L, Santini F, Vitti P, Bendinelli G, Pinchera A 1994 Appearance of thyroid stimulating antibody and Graves' disease after radioiodine therapy for toxic nodular goitre. Clin Endocrinol (Oxf) 40:803-806
17. Mariotti S, Martino E, Francesconi M, Ceccarelli C, Grasso L, Lippi F, Banchieri L, Pinchera A 1986 Serum thyroid autoantibodies as a risk factor for development of hypothyroidism after radioactive iodine therapy for single thyroid 'hot' nodule. Acta Endocrinol (Copenh) 113:500-507
18. Einhorn J, Fagraeus A, Jonsson J 1965 Thyroid antibodies after 131-I treatment for hyperthyroidism. J Clin Endocrinol Metab 25:1218-1224
19. Fenzi GF, Hashaizume K, Roudebush CP, De Groot LJ 1979 Changes in thyroid stimulating immunoglobulins during antithyroid therapy. J Clin Endocrinol Metab 48:572-576
20. O'Gorman P, Staffuerth JS, Ballentyne MR 1964 Antibody response to thyroid irradiation. J Clin Endocrinol Metab 24:1072-1075
21. Pinchera A, Liberti P, Martino E, Fenzi GF, Grasso L, Rovis L, Banchieri L 1969 Effects of antithyroid therapy on the long-acting thyroid stimulator and the antithyroglobulin antibodies. J Clin Endocrinol Metab 29:231-238
22. Chiovato L, Lapi P, Fiore E, Tonacchera M, Pinchera A 1993 Thyroid autoimmunity and female gender. J Endocrinol Invest 16:373-401
23. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, Grimlev Evans J, Hasan DM, Rodgers H, Tunbridge F 1995 The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 43:55-68
24. Nagataki S, Shibata Y, Inoue S, Yokoyama N, Izumi M, Shimaoka K 1994 Thyroid disease among atomic bomb survivors. JAMA 272: 364-370
25. Imaizumi M, Usa T, Tominaga T, Neriishi K, Akahoshi M, Nakashima E, Ashizawa K, Hida A, Soda M, Fujiwara S, Yamada M, Ejima E, Yokoyama N, Okubo M, Sugino K, Suzuki G, Maeda R, Nagataki S, Eguchi K 2006 Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in Hiroshima and Nagasaki atomic bomb survivors 55-58 years after radiation exposure. JAMA 295:1011-1022